Anemia Management in Patients with Heart Failure, Chronic Kidney Disease, and Recent Cancer

Initial Evaluation and Diagnosis

The American Journal of Kidney Diseases recommends iron studies, including serum ferritin and transferrin saturation, as mandatory for patients with anemia and CKD, as iron deficiency is present in 25-37.5% of these patients 3, 1
A complete blood count with differential is essential to exclude bone marrow dysfunction or malignancy recurrence, according to the American Journal of Kidney Diseases 3, 1
The Journal of Crohn's and Colitis suggests checking inflammatory markers, such as C-reactive protein, as inflammation can falsely elevate ferritin and mask true iron deficiency 4, 2
The American Journal of Kidney Diseases recommends assessing for gastrointestinal bleeding, particularly in patients with a history of colon cancer, using stool guaiac or fecal immunochemical test 3, 1

The Journal of Crohn's and Colitis defines absolute iron deficiency as ferritin <100 μg/L in the presence of inflammation, and functional iron deficiency as TSAT <20% even with ferritin 30-100 μg/L 4, 1
The Kidney International journal states that intravenous iron is strongly preferred over oral iron in patients with severe anemia, multiple comorbidities, and likely poor oral absorption with CKD 5, 4
The Journal of Crohn's and Colitis notes that oral iron has limitations, including gastrointestinal side effects, and is poorly tolerated, while intravenous iron is more effective and better tolerated 4

The Kidney International journal recommends exercising extreme caution with erythropoiesis-stimulating agents (ESAs) in patients with a history of malignancy, particularly when cure is anticipated 5
The Kidney International journal suggests that ESAs should only be considered if iron replacement fails, the patient has severe symptoms, and the oncologist confirms no active malignancy and low recurrence risk 5
The European Heart Journal recommends avoiding NSAIDs in patients with heart failure due to fluid retention and renal toxicity 6

The Praxis Medical Insights guideline recommends monitoring hemoglobin weekly until stable after any intervention, and then monthly in CKD patients with anemia 2
The Journal of Crohn's and Colitis notes that recurrence of anemia is common, affecting >50% of successfully treated patients within 1 year, often indicating ongoing inflammation 4